Nexalin Technology (NXL) Research & Development (2024 - 2026)
Nexalin Technology's (NXL) quarterly Research & Development came in at $346382.0 in Q1 2026, down 14.74% year-on-year from $406288.0 in Q1 2025, and up 53.99% quarter-over-quarter from $224940.0 in Q4 2025.
Nexalin Technology (NXL) Research & Development (2024 - 2026) Analysis & Trends
Nexalin Technology's Research & Development history runs 3 years deep, the most recent figure standing at $346382.0 for Q1 2026.
- On a quarterly basis, Research & Development fell 14.74% year-over-year to $346382.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 31.37% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 9.02% from the prior year.
- Research & Development improved to $346382.0 in Q1 2026 per NXL's latest filing, from $224940.0 in the prior quarter.
- Across five years, Research & Development topped out at $737242.0 in Q4 2024 and bottomed at $105668.0 in Q1 2024.
- The 3-year median for Research & Development is $225774.0 (2025), against an average of $291198.8.
- Biggest YoY gain for Research & Development was 284.49% in 2025; the steepest drop was 69.49% in 2025.
- Year by year, Research & Development stood at $737242.0 in 2024, then tumbled by 69.49% to $224940.0 in 2025, then soared by 53.99% to $346382.0 in 2026.
- Per Business Quant, the three latest NXL Research & Development figures stand at $346382.0 (Q1 2026), $224940.0 (Q4 2025), and $226520.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 346,382.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346,382.00 |
| Dec 31, 2025 | 224,940.00 |
| Sep 30, 2025 | 226,520.00 |
| Jun 30, 2025 | 225,774.00 |
| Mar 31, 2025 | 406,288.00 |
| Dec 31, 2024 | 737,242.00 |
| Sep 30, 2024 | 178,565.00 |
| Jun 30, 2024 | 169,410.00 |
| Mar 31, 2024 | 105,668.00 |